Incyte Biosciences Benelux
1 clinical trials · Sponsor
◉ Watch Incyte Biosciences Benelux
| Record | Firm | Date |
|---|---|---|
| Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium (NCT03678454) | Incyte Biosciences Benelux | 2017-02-03 |
Track Incyte Biosciences Benelux automatically
Every clearance here is in the API, with alerts when new ones post.